Statistics at a Glance

At a Glance

Estimated New Cases in 2020 191,930

% of All New Cancer Cases 10.6%

Estimated Deaths in 2020 33,330

% of All Cancer Deaths 5.5%

5-Year
Relative Survival

97.8% 2010–2016
Year Rate of New Cases — SEER 9 Rate of New Cases — SEER 13 Death Rate — U.S. 5-Year Relative Survival — SEER 9
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 94.00 92.87 - - 30.97 31.42 66.45% 66.87%
1976 97.95 95.30 - - 31.78 31.71 68.65% 67.76%
1977 100.48 97.79 - - 31.83 32.00 69.11% 68.63%
1978 99.40 100.35 - - 32.66 32.29 69.46% 69.49%
1979 103.42 102.97 - - 32.84 32.58 71.34% 70.32%
1980 106.05 105.66 - - 33.05 32.87 70.50% 71.14%
1981 108.88 108.42 - - 33.17 33.17 72.01% 71.94%
1982 108.25 111.25 - - 33.36 33.47 72.16% 72.72%
1983 111.65 114.16 - - 33.92 33.78 72.77% 73.48%
1984 111.70 117.14 - - 34.06 34.08 73.39% 74.23%
1985 115.52 120.20 - - 33.91 34.39 75.21% 74.96%
1986 119.10 123.34 - - 34.93 34.70 77.24% 75.67%
1987 133.78 126.57 - - 35.11 35.02 80.77% 80.35%
1988 137.65 129.87 - - 35.88 36.08 83.45% 84.22%
1989 145.43 150.79 - - 37.10 37.18 84.64% 87.39%
1990 171.14 175.08 - - 38.56 38.31 88.70% 89.96%
1991 214.89 203.27 - - 39.31 39.47 92.96% 92.03%
1992 237.60 236.01 234.27 232.52 39.22 39.28 96.28% 93.69%
1993 209.67 213.64 207.19 206.66 39.34 39.09 95.41% 95.01%
1994 180.43 193.39 177.62 183.67 38.54 38.90 94.87% 96.07%
1995 169.55 175.05 166.68 163.24 37.29 37.25 95.94% 96.90%
1996 169.68 174.70 166.91 166.73 36.00 35.67 96.66% 97.56%
1997 173.83 174.35 172.08 170.28 34.15 34.16 97.71% 98.08%
1998 171.25 174.00 169.91 173.92 32.63 32.71 98.40% 98.49%
1999 183.72 173.64 180.50 177.63 31.56 31.57 99.47% 98.81%
2000 183.37 173.29 179.14 181.42 30.39 30.48 99.08% 99.07%
2001 185.41 172.94 180.40 177.81 29.52 29.42 99.98% 99.27%
2002 182.74 172.59 178.24 174.27 28.71 28.39 99.92% 99.42%
2003 170.19 172.24 165.75 170.80 27.19 27.41 99.54% 99.55%
2004 166.36 171.90 165.78 167.40 26.19 26.46 99.82% 99.64%
2005 157.10 171.55 154.39 164.07 25.40 25.54 99.36% 99.72%
2006 172.69 171.20 165.13 160.81 24.24 24.65 99.81% 99.78%
2007 175.79 170.86 168.54 157.61 24.23 23.79 99.89% 99.70%
2008 158.65 170.51 154.01 154.47 23.01 22.97 99.45% 99.59%
2009 155.82 156.86 150.96 151.40 22.12 22.17 99.47% 99.44%
2010 148.40 144.30 144.39 148.38 21.81 21.40 99.59% 99.23%
2011 142.31 132.75 138.32 133.48 20.79 20.65 99.35% 98.94%
2012 116.37 122.12 113.17 120.08 19.57 19.94 98.23% 98.55%
2013 111.15 112.35 107.67 108.03 19.28 19.24 - 98.01%
2014 102.02 103.35 98.83 97.18 19.12 19.18 - 97.29%
2015 107.88 107.07 101.91 100.68 18.96 19.12 - 96.30%
2016 110.01 110.92 103.74 104.31 19.40 19.06 - 94.95%
2017 115.24 114.91 108.05 108.07 18.85 19.00 - 93.14%

New cases come from SEER 13. Deaths come from U.S. Mortality.
All Races, Males. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.

New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.


Rate of New Cases and Deaths per 100,000: The rate of new cases of prostate cancer was 109.8 per 100,000 men per year. The death rate was 19.1 per 100,000 men per year. These rates are age-adjusted and based on 2013–2017 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 12.1 percent of men will be diagnosed with prostate cancer at some point during their lifetime, based on 2015–2017 data.

Prevalence of This Cancer: In 2017, there were an estimated 3,170,339 men living with prostate cancer in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Prostate Cancer?

Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

97.8%

5-Year
Relative Survival

97.8%

Based on data from SEER 18 2010–2016. Gray figures represent those who have died from prostate cancer. Green figures represent those who have survived 5 years or more.

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. For prostate cancer, 75.9% are diagnosed at the local stage. The 5-year relative survival for localized prostate cancer is 100.0%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Prostate Cancer
Stage Percent of Cases 5-Year Relative Survival
Localized
Confined to Primary Site
76% 100.0%
Regional
Spread to Regional Lymph Nodes
13% 100.0%
Distant
Cancer Has Metastasized
6% 30.2%
Unknown
Unstaged
5% 83.3%

SEER 18 2010–2016, All Races, Males by SEER Summary Stage 2000

New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, prostate cancer is fairly common.

Rank Common Types of Cancer Estimated New
Cases 2020
Estimated
Deaths 2020
1. Breast Cancer (Female) 276,480 42,170
2. Lung and Bronchus Cancer 228,820 135,720
3. Prostate Cancer 191,930 33,330
4. Colorectal Cancer 147,950 53,200
5. Melanoma of the Skin 100,350 6,850
6. Bladder Cancer 81,400 17,980
7. Non-Hodgkin Lymphoma 77,240 19,940
8. Kidney and Renal Pelvis Cancer 73,750 14,830
9. Uterine Cancer 65,620 12,590
10. Leukemia 60,530 23,100

Prostate cancer represents 10.6% of all new cancer cases in the U.S.

10.6%

In 2020, it is estimated that there will be 191,930 new cases of prostate cancer and an estimated 33,330 people will die of this disease.

Who Gets This Cancer?

Prostate cancer occurs only in men, and it is more common in older men than younger men. It is more likely to occur in men with a family history of prostate cancer and men of African American descent. The rate of new cases of prostate cancer was 109.8 per 100,000 men per year based on 2013–2017 cases, age-adjusted.

Rate of New Cases per 100,000 Persons by Race/Ethnicity: Prostate Cancer
Males
All Races 109.8
White 102.3
Black 175.2
Asian/Pacific Islander 56.7
American Indian/Alaska Native 54.6
Hispanic 92.0
Non-Hispanic 112.6
Females
All Races Sex-specific cancer type
White
Black
Asian/Pacific Islander
American Indian/Alaska Native
Hispanic
Non-Hispanic

SEER 21 2013–2017, Age-Adjusted

Percent of New Cases by Age Group: Prostate Cancer
Age Range Percent of New Cases
<20 0.0%
20–34 0.0%
35–44 0.4%
45–54 8.1%
55–64 32.4%
65–74 39.9%
75–84 15.1%
>84 4.1%

Prostate cancer is most frequently diagnosed among men aged 65–74.

Median Age
At Diagnosis

66

SEER 21 2013–2017, All Races, Males

Who Dies From This Cancer?

Because we have screening for prostate cancer, most of the time it is caught before it spreads to other parts of the body. Men who have prostate cancer that is characterized as localized or regional are not as likely to die as men whose cancer is distant. In general prostate cancer has excellent survival rates, but death rates are higher in African American men, men who have advanced stage cancer, and men who are between the ages of 75 and 84. Prostate cancer is the fifth leading cause of cancer death in the United States. The death rate was 19.1 per 100,000 men per year based on 2013–2017, age-adjusted.

Death Rate per 100,000 Persons by Race/Ethnicity: Prostate Cancer
Males
All Races 19.1
White 17.9
Black 37.9
Asian/Pacific Islander 8.6
American Indian/Alaska Native 18.7
Hispanic 15.8
Non-Hispanic 19.4
Females
All Races Sex-specific cancer type
White
Black
Asian/Pacific Islander
American Indian/Alaska Native
Hispanic
Non-Hispanic

U.S. 2013–2017, Age-Adjusted

Percent of Deaths by Age Group: Prostate Cancer
Age Range Percent of Deaths
<20 0.0%
20–34 0.0%
35–44 0.1%
45–54 1.4%
55–64 9.3%
65–74 22.7%
75–84 33.3%
>84 33.2%

The percent of prostate cancer deaths is highest among men aged 75–84.

Median Age
At Death

80

U.S. 2013–2017, All Races, Males

Trends in Rates

Changes Over Time

Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, age-adjusted rates for new prostate cancer cases have been falling on average 4.3% each year over the last 10 years. Age-adjusted death rates have been falling on average 2.1% each year over 2008–2017. 5-year relative survival trends are shown below.

Interactive Statistics with SEER*Explorer

With SEER*Explorer, you can...
  • Create custom graphs and tables
  • Download data and images
  • Share links to results

SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.

Explore Additional Prostate Cancer Statistics

More About This Cancer

Cancer and the Prostate

Figure: Prostate and Nearby Organs

Figure: Anatomy diagram shows the prostate, urethra, penis, testicle, bladder, lymph nodes, seminal vesicle, and rectum are labeled. An inset provides a close-up view of the prostate, urethra, bladder, seminal vesicles, and rectum.

This cancer forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). The prostate surrounds the urethra, the tube through which urine flows. A healthy prostate is about the size of a walnut. If the prostate grows too large, it squeezes the urethra. This may slow or stop the normal flow of urine. Prostate cancer usually occurs in older men.

Additional Information

More Information

Here are some resources for learning more about prostate cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Prostate Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/prost.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used.

Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.